Skip to main content
Erschienen in: Rheumatology International 9/2013

01.09.2013 | Original Article

Skin ulcer is a predictive and prognostic factor of acute or subacute interstitial lung disease in dermatomyositis

verfasst von: Kazuyoshi Ishigaki, Junko Maruyama, Noboru Hagino, Atsuko Murota, Yasunobu Takizawa, Ran Nakashima, Tsuneyo Mimori, Keigo Setoguchi

Erschienen in: Rheumatology International | Ausgabe 9/2013

Einloggen, um Zugang zu erhalten

Abstract

The aim of this study was to determine whether skin ulcer can be used as a predictive and prognostic factor of acute/subacute interstitial lung disease (ILD) in Japanese patients with dermatomyositis (DM). We reviewed the medical records of 39 consecutive DM patients who were admitted to Tokyo Metropolitan Komagome Hospital from January 2000 to December 2009. The mean follow-up period was 63.9 ± 51.6 months. Fifteen patients had acute/subacute ILD and 11 patients had chronic ILD. Seven out of 15 acute/subacute ILD led to respiratory failure and 3 of them died due to ILD. Skin ulcers were observed in 5 out of 15 patients with acute/subacute ILD (33.3 %) and in 2 out of 24 patients without acute/subacute ILD (8.3 %). The presence of skin ulcers was revealed to be a significant predictive factor for acute/subacute ILD among various parameters by multivariate analysis. In the 15 patients with acute/subacute ILD, the presence of skin ulcers was a significant poor prognostic factor (p = 0.0231) and the cumulative survival rate of patients with skin ulcers was 53.3 % for 12 months. Skin ulcer is a significant predictive and prognostic factor of acute/subacute ILD in patients with DM.
Literatur
1.
Zurück zum Zitat Won Huh J, Soon Kim D, Keun Lee C, Yoo B, Bum Seo J, Kitaichi M et al (2007) Two distinct clinical types of interstitial lung disease associated with polymyositis-dermatomyositis. Respir Med 101(8):1761–1769PubMedCrossRef Won Huh J, Soon Kim D, Keun Lee C, Yoo B, Bum Seo J, Kitaichi M et al (2007) Two distinct clinical types of interstitial lung disease associated with polymyositis-dermatomyositis. Respir Med 101(8):1761–1769PubMedCrossRef
2.
Zurück zum Zitat Kang EH, Lee EB, Shin KC, Im CH, Chung DH, Han SK et al (2005) Interstitial lung disease in patients with polymyositis, dermatomyositis and amyopathic dermatomyositis. Rheumatology (Oxford) 44(10):1282–1286CrossRef Kang EH, Lee EB, Shin KC, Im CH, Chung DH, Han SK et al (2005) Interstitial lung disease in patients with polymyositis, dermatomyositis and amyopathic dermatomyositis. Rheumatology (Oxford) 44(10):1282–1286CrossRef
3.
Zurück zum Zitat Chen IJ, Jan Wu YJ, Lin CW, Fan KW, Luo SF, Ho HH et al (2009) Interstitial lung disease in polymyositis and dermatomyositis. Clin Rheumatol 28(6):639–646PubMedCrossRef Chen IJ, Jan Wu YJ, Lin CW, Fan KW, Luo SF, Ho HH et al (2009) Interstitial lung disease in polymyositis and dermatomyositis. Clin Rheumatol 28(6):639–646PubMedCrossRef
4.
Zurück zum Zitat Fathi M, Lundberg IE (2005) Interstitial lung disease in polymyositis and dermatomyositis. Curr Opin Rheumatol 17(6):701–706PubMedCrossRef Fathi M, Lundberg IE (2005) Interstitial lung disease in polymyositis and dermatomyositis. Curr Opin Rheumatol 17(6):701–706PubMedCrossRef
5.
Zurück zum Zitat Marie I, Hachulla E, Cherin P, Dominique S, Hatron PY, Hellot MF et al (2002) Interstitial lung disease in polymyositis and dermatomyositis. Arthritis Rheum 47(6):614–622PubMedCrossRef Marie I, Hachulla E, Cherin P, Dominique S, Hatron PY, Hellot MF et al (2002) Interstitial lung disease in polymyositis and dermatomyositis. Arthritis Rheum 47(6):614–622PubMedCrossRef
6.
Zurück zum Zitat Gono T, Kawaguchi Y, Hara M, Masuda I, Katsumata Y, Shinozaki M et al (2010) Increased ferritin predicts development and severity of acute interstitial lung disease as a complication of dermatomyositis. Rheumatology (Oxford) 49(7):1354–1360CrossRef Gono T, Kawaguchi Y, Hara M, Masuda I, Katsumata Y, Shinozaki M et al (2010) Increased ferritin predicts development and severity of acute interstitial lung disease as a complication of dermatomyositis. Rheumatology (Oxford) 49(7):1354–1360CrossRef
7.
Zurück zum Zitat Kameda H, Nagasawa H, Ogawa H, Sekiguchi N, Takei H, Tokuhira M et al (2005) Combination therapy with corticosteroids, cyclosporin A, and intravenous pulse cyclophosphamide for acute/subacute interstitial pneumonia in patients with dermatomyositis. J Rheumatol 32(9):1719–1726PubMed Kameda H, Nagasawa H, Ogawa H, Sekiguchi N, Takei H, Tokuhira M et al (2005) Combination therapy with corticosteroids, cyclosporin A, and intravenous pulse cyclophosphamide for acute/subacute interstitial pneumonia in patients with dermatomyositis. J Rheumatol 32(9):1719–1726PubMed
8.
Zurück zum Zitat Ideura G, Hanaoka M, Koizumi T, Fujimoto K, Shimojima Y, Ishii W et al (2007) Interstitial lung disease associated with amyopathic dermatomyositis: review of 18 cases. Respir Med 101(7):1406–1411PubMedCrossRef Ideura G, Hanaoka M, Koizumi T, Fujimoto K, Shimojima Y, Ishii W et al (2007) Interstitial lung disease associated with amyopathic dermatomyositis: review of 18 cases. Respir Med 101(7):1406–1411PubMedCrossRef
9.
Zurück zum Zitat Ye S, Chen XX, Lu XY, Wu MF, Deng Y, Huang WQ et al (2007) Adult clinically amyopathic dermatomyositis with rapid progressive interstitial lung disease: a retrospective cohort study. Clin Rheumatol 26(10):1647–1654PubMedCrossRef Ye S, Chen XX, Lu XY, Wu MF, Deng Y, Huang WQ et al (2007) Adult clinically amyopathic dermatomyositis with rapid progressive interstitial lung disease: a retrospective cohort study. Clin Rheumatol 26(10):1647–1654PubMedCrossRef
10.
Zurück zum Zitat Mimori A, Suzuki T, Satoh N, Nara H, Masuyama J, Yoshio T et al (2000) Dermatomyositis and cutaneous necrosis: report of five cases. Mod Rheumatol 10:117–120CrossRef Mimori A, Suzuki T, Satoh N, Nara H, Masuyama J, Yoshio T et al (2000) Dermatomyositis and cutaneous necrosis: report of five cases. Mod Rheumatol 10:117–120CrossRef
11.
Zurück zum Zitat Sato S, Hirakata M, Kuwana M, Suwa A, Inada S, Mimori T et al (2005) Autoantibodies to a 140-kd polypeptide, CADM-140, in Japanese patients with clinically amyopathic dermatomyositis. Arthritis Rheum 52(5):1571–1576PubMedCrossRef Sato S, Hirakata M, Kuwana M, Suwa A, Inada S, Mimori T et al (2005) Autoantibodies to a 140-kd polypeptide, CADM-140, in Japanese patients with clinically amyopathic dermatomyositis. Arthritis Rheum 52(5):1571–1576PubMedCrossRef
12.
Zurück zum Zitat Nakashima R, Imura Y, Kobayashi S, Yukawa N, Yoshifuji H, Nojima T et al (2010) The RIG-I-like receptor IFIH1/MDA5 is a dermatomyositis-specific autoantigen identified by the anti-CADM-140 antibody. Rheumatology (Oxford) 49(3):433–440CrossRef Nakashima R, Imura Y, Kobayashi S, Yukawa N, Yoshifuji H, Nojima T et al (2010) The RIG-I-like receptor IFIH1/MDA5 is a dermatomyositis-specific autoantigen identified by the anti-CADM-140 antibody. Rheumatology (Oxford) 49(3):433–440CrossRef
13.
Zurück zum Zitat Gerami P, Schope JM, McDonald L, Walling HW, Sontheimer RD (2006) A systematic review of adult-onset clinically amyopathic dermatomyositis (dermatomyositis sine myositis): a missing link within the spectrum of the idiopathic inflammatory myopathies. J Am Acad Dermatol 54(4):597–613PubMedCrossRef Gerami P, Schope JM, McDonald L, Walling HW, Sontheimer RD (2006) A systematic review of adult-onset clinically amyopathic dermatomyositis (dermatomyositis sine myositis): a missing link within the spectrum of the idiopathic inflammatory myopathies. J Am Acad Dermatol 54(4):597–613PubMedCrossRef
14.
Zurück zum Zitat American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS). Am J Respir Crit Care Med. 2000 Feb; 161(2 Pt 1):646–664 American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS). Am J Respir Crit Care Med. 2000 Feb; 161(2 Pt 1):646–664
15.
Zurück zum Zitat Suda T, Fujisawa T, Enomoto N, Nakamura Y, Inui N, Naito T et al (2006) Interstitial lung diseases associated with amyopathic dermatomyositis. Eur Respir J 28(5):1005–1012PubMedCrossRef Suda T, Fujisawa T, Enomoto N, Nakamura Y, Inui N, Naito T et al (2006) Interstitial lung diseases associated with amyopathic dermatomyositis. Eur Respir J 28(5):1005–1012PubMedCrossRef
16.
Zurück zum Zitat Cicuttini FM, Fraser KJ (1989) Recurrent pneumomediastinum in adult dermatomyositis. J Rheumatol 16(3):384–386PubMed Cicuttini FM, Fraser KJ (1989) Recurrent pneumomediastinum in adult dermatomyositis. J Rheumatol 16(3):384–386PubMed
17.
Zurück zum Zitat Yosipovitch G, Feinmesser M, David M (1998) Adult dermatomyositis with livedo reticularis and multiple skin ulcers. J Eur Acad Dermatol Venereol 11(1):48–50PubMedCrossRef Yosipovitch G, Feinmesser M, David M (1998) Adult dermatomyositis with livedo reticularis and multiple skin ulcers. J Eur Acad Dermatol Venereol 11(1):48–50PubMedCrossRef
18.
Zurück zum Zitat Jang KA, Kim SH, Choi JH, Sung KJ, Moon KC, Koh JK (1999) Subcutaneous emphysema with spontaneous pneumomediastinum and pneumothorax in adult dermatomyositis. J Dermatol 26(2):125–127PubMed Jang KA, Kim SH, Choi JH, Sung KJ, Moon KC, Koh JK (1999) Subcutaneous emphysema with spontaneous pneumomediastinum and pneumothorax in adult dermatomyositis. J Dermatol 26(2):125–127PubMed
19.
Zurück zum Zitat Tsujimura S, Saito K, Tanaka Y (2008) Complete resolution of dermatomyositis with refractory cutaneous vasculitis by intravenous cyclophosphamide pulse therapy. Intern Med 47(21):1935–1940PubMedCrossRef Tsujimura S, Saito K, Tanaka Y (2008) Complete resolution of dermatomyositis with refractory cutaneous vasculitis by intravenous cyclophosphamide pulse therapy. Intern Med 47(21):1935–1940PubMedCrossRef
20.
Zurück zum Zitat Yamamoto T, Ohkubo H, Katayama I, Nishioka K (1994) Dermatomyositis with multiple skin ulcers showing vasculitis and membrano-cystic lesion. J Dermatol 21(9):687–689PubMed Yamamoto T, Ohkubo H, Katayama I, Nishioka K (1994) Dermatomyositis with multiple skin ulcers showing vasculitis and membrano-cystic lesion. J Dermatol 21(9):687–689PubMed
21.
Zurück zum Zitat Scheinfeld NS (2006) Ulcerative paraneoplastic dermatomyositis secondary to metastatic breast cancer. Skinmed 5(2):94–96PubMedCrossRef Scheinfeld NS (2006) Ulcerative paraneoplastic dermatomyositis secondary to metastatic breast cancer. Skinmed 5(2):94–96PubMedCrossRef
22.
Zurück zum Zitat Pusceddu V, Frau B, Guerzoni D, Catani G, Murgia M, Murru M et al (2008) Undescribed case of necrotic ulcerative amyopathic dermatomyositis in bone metastatic breast cancer. Breast J 14(6):591–592PubMedCrossRef Pusceddu V, Frau B, Guerzoni D, Catani G, Murgia M, Murru M et al (2008) Undescribed case of necrotic ulcerative amyopathic dermatomyositis in bone metastatic breast cancer. Breast J 14(6):591–592PubMedCrossRef
23.
Zurück zum Zitat Sigurgeirsson B, Lindelof B, Edhag O, Allander E (1992) Risk of cancer in patients with dermatomyositis or polymyositis. A population-based study. N Engl J Med 326(6):363–367PubMedCrossRef Sigurgeirsson B, Lindelof B, Edhag O, Allander E (1992) Risk of cancer in patients with dermatomyositis or polymyositis. A population-based study. N Engl J Med 326(6):363–367PubMedCrossRef
24.
Zurück zum Zitat Mukae H, Ishimoto H, Sakamoto N, Hara S, Kakugawa T, Nakayama S et al (2009) Clinical differences between interstitial lung disease associated with clinically amyopathic dermatomyositis and classic dermatomyositis. Chest 136(5):1341–1347PubMedCrossRef Mukae H, Ishimoto H, Sakamoto N, Hara S, Kakugawa T, Nakayama S et al (2009) Clinical differences between interstitial lung disease associated with clinically amyopathic dermatomyositis and classic dermatomyositis. Chest 136(5):1341–1347PubMedCrossRef
25.
Zurück zum Zitat Kameda H, Takeuchi T (2006) Recent advances in the treatment of interstitial lung disease in patients with polymyositis/dermatomyositis. Endocr Metab Immune Disord Drug Targets 6(4):409–415PubMedCrossRef Kameda H, Takeuchi T (2006) Recent advances in the treatment of interstitial lung disease in patients with polymyositis/dermatomyositis. Endocr Metab Immune Disord Drug Targets 6(4):409–415PubMedCrossRef
Metadaten
Titel
Skin ulcer is a predictive and prognostic factor of acute or subacute interstitial lung disease in dermatomyositis
verfasst von
Kazuyoshi Ishigaki
Junko Maruyama
Noboru Hagino
Atsuko Murota
Yasunobu Takizawa
Ran Nakashima
Tsuneyo Mimori
Keigo Setoguchi
Publikationsdatum
01.09.2013
Verlag
Springer Berlin Heidelberg
Erschienen in
Rheumatology International / Ausgabe 9/2013
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-013-2735-y

Weitere Artikel der Ausgabe 9/2013

Rheumatology International 9/2013 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.